PRESS RELEASEAB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2024 AND THE KEY EVENTS OF THE PERIOD Financial and corporate situation Operating deficit of 6,1 million euros as of ...

ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (the "Company", "Zefiro", or "ZEFI") today announced the Company's consolidated financial results for the fiscal quarter that ended March 31, 2025 ("fiscal ...

“It seems to help with a stickiness in staying with Equity,” she observed.

Mersana Therapeutics restructures to focus on breast cancer, extends cash runway to mid-2026, and reports promising Emi-Le progress in TNBC.

Copyright © 2025 MarketWatch, Inc. All rights reserved.